1 year-Real world clinical audit of aflibercept use in the management of macular edema secondary to central retinal vein occlusion at Moorfields Eye Hospital

Vrizidou Eleni; Eleftheriadou Maria; Zacharaki Fani; Addison Peter

首页> 外文期刊>Investigative ophthalmology & visual science >1 year-Real world clinical audit of aflibercept use in the management of macular edema secondary to central retinal vein occlusion at Moorfields Eye Hospital

【24h】

1 year-Real world clinical audit of aflibercept use in the management of macular edema secondary to central retinal vein occlusion at Moorfields Eye Hospital

机译：1年 - 真实世界临床审计在Moorfields眼科医院管理中，在Mallumed Matema中的Mallume Dema中的管理中使用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2017年第8期|共3页
作者
Vrizidou Eleni; Eleftheriadou Maria; Zacharaki Fani; Addison Peter;
展开▼
作者单位

Moorfields Eye Hosp Med Retina London England;

Moorfields Eye Hosp Med Retina London England;

Moorfields Eye Hosp Med Retina London England;

Moorfields Eye Hosp Med Retina London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. 1 year-Real world clinical audit of aflibercept use in the management of macular edema secondary to central retinal vein occlusion at Moorfields Eye Hospital [J] . Vrizidou Eleni, Eleftheriadou Maria, Zacharaki Fani, Investigative ophthalmology & visual science . 2017,第8期

机译：1年 - 真实世界临床审计在Moorfields眼科医院管理中，在Mallumed Matema中的Mallume Dema中的管理中使用
2. Real world clinical audit of aflibercept for management of macular edema secondary to central retinal vein occlusion [J] . Pakzad-Vaezi Kaivon, El-Atfy Mohammed, Vrizidou Eleni, Investigative ophthalmology & visual science . 2016,第12期

机译：AfliBercept的现实世界临床审计，用于MATIMER DEMA的MATIMER DEMA静脉闭塞
3. Real world clinical audit of aflibercept and ranibizumab use in the management of macular oedema secondary to central retinal vein occlusion [J] . Elatfy Mohammed, Than Jonathan, Palexas George Investigative ophthalmology & visual science . 2018,第9期

机译：AfliBelcept和Ranibizumab的现实世界临床审计在Marcular Dema中的管理中的次级视网膜静脉闭塞
4. Morphology of vascular network in eyes with diabetic macular edema varies based on tolerance of aflibercept treatment interval length: preliminary findings [C] . Prateek Prasanna, Justis Ehlers, Nathaniel Braman, Biomedical Applications in Molecular, Structural, and Functional Imaging . 2019

机译：患有糖尿病黄斑水肿的眼睛中血管网络的形态基于AfliBercept治疗间隔长度的耐受性因耐受性而变化：初步调查结果
5. Factors associated with degree of adoption by hospitals in the central states of the Agency for Health Care Policy and Research clinical practice guideline for management of cancer pain [D] . Spies, Martha Ann Enzenauer 2000

机译：与中央政府卫生局政策和研究机构临床实践指南对癌症疼痛的管理所采用的程度有关的因素
6. Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion [O] . Cem Ozgonul, Vaidehi S. Dedania, Cagri G. Besirli -1

机译：阿柏西普与贝伐单抗和/或雷珠单抗治疗继发于视网膜中央静脉阻塞的复发性黄斑水肿
7. Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion [O] . Philip Hykin, A. Toby Prevost, Joana C. Vasconcelos, 2019

机译：含有Ranibizumab的宫腔治疗的临床疗效与阿昔普菌与中央视网膜静脉闭塞的黄斑水肿对贝伐自烟草

1 year-Real world clinical audit of aflibercept use in the management of macular edema secondary to central retinal vein occlusion at Moorfields Eye Hospital

著录项

相似文献

相关主题

期刊订阅